National Drug Abuse Treatment 

 DELAWARE VALLEY NODE


DELAWARE VALLEY NODE

George E. Woody, M.D. [email]
Principal Investigator

Professor
Department of Psychiatry
University of Pennsylvania
Treatment Research Institute
600 Public Ledger Bldg.
150 S. Independence Mall - West
Philadelphia, PA 19106-3475
http://www.med.upenn.edu/csa/trials_network.html (Node)
http://www.tresearch.org/ctn/ctn.htm (Node)
http://www.nida.nih.gov/CTN/centers/Delaware.html (NIDA)

The Delaware Valley Node joined the Clinical Trials Network in September 1999. This Node is part of the Center for Studies of Addiction at the University of Pennsylvania and the Treatment Research Institute in Philadelphia (the Regional Research and Training Center (RRTC)); and is also affiliated with Thomas Jefferson University School of Medicine and the University of Medicine and Dentistry of New Jersey. There are 15 CTPs in its provider network; serving residents of New Jersey, Pennsylvania and Delaware; in addition, the DV Node includes one managed behavioral health care organization with over 500,000 Philadelphia area members. The DV Node member organizations provide services to patients with every type of substance use disorder including special populations such as: 1) persons living with HIV, 2) adolescents, 3) veterans, 4) women with children, and 5) patients living in rural areas.


  Find publications in the Library with Delaware Valley involvement

 

  DELAWARE VALLEY NODE PROTOCOL INVOLVEMENT

CTN-0002 Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification

CTN-0004 MET to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse

CTN-0006 Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics

CTN-0007 Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics

CTN-0008 Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation

CTN-0010 Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescent/Young Adults

CTN-0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs

CTN-0018 Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment

CTN-0019 Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment

CTN-0027 Starting Treatment with Agonist Replacement Therapies (START)

CTN-0027-A-1 START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies

CTN-0027-A-2 Retention of Suboxone Patients in START: Perspectives of Providers and Patients

CTN-0028 Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents (with Substance Use Disorder)

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 7/2010 -- http://ctndisseminationlibrary.org/nodes/dvnode.htm
info@ctndisseminationlibrary.org